173 related articles for article (PubMed ID: 9814467)
1. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.
Figueroa-Vega N; Sanz-Cameno P; Moreno-Otero R; Sánchez-Madrid F; González-Amaro R; Marazuela M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1145-53. PubMed ID: 19141578
[TBL] [Abstract][Full Text] [Related]
3. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E
Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913
[TBL] [Abstract][Full Text] [Related]
4. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
[TBL] [Abstract][Full Text] [Related]
5. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
6. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
[TBL] [Abstract][Full Text] [Related]
7. [The influence of thyroidectomy of serum VEGF levels in patients with Graves disease].
Kołomecki K; Bartos M; Pomorski L; Kuzdak K
Wiad Lek; 2001; 54(9-10):504-7. PubMed ID: 11816293
[TBL] [Abstract][Full Text] [Related]
8. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
[TBL] [Abstract][Full Text] [Related]
10. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
[TBL] [Abstract][Full Text] [Related]
11. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
13. Circulating chemokines in patients with autoimmune thyroid diseases.
Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
[TBL] [Abstract][Full Text] [Related]
15. The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.
Farhangi MA; Dehghan P; Tajmiri S; Abbasi MM
BMC Complement Altern Med; 2016 Nov; 16(1):471. PubMed ID: 27852303
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
17. A preliminary clinical application of sICAM-1 RIA in three kinds of thyroid disease.
Lu M; Fang P; Zhang Z; He H; Gao S; Hou B; Zheng R; Xiao Q; Yang L
Chin Med J (Engl); 2002 Oct; 115(10):1552-5. PubMed ID: 12490109
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
Wang CY; Chang TC
J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 levels in patients with disorders of the thyroid gland.
Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C
Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
[TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases.
Rancier M; Zaaber I; Stathopoulou MG; Chatelin J; Saleh A; Marmouch H; El Shamieh S; Masson C; Murray H; Lamont J; Fitzgerald P; Mahjoub S; Said K; Tensaout BB; Mestiri S; Visvikis-Siest S
Autoimmunity; 2016 Sep; 49(6):366-372. PubMed ID: 27494076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
